- Start
- Early Phase Cancer Immunotherapy
Early Phase Cancer Immunotherapy
Angebote / Angebote:
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Lieferbar in ca. 20-45 Arbeitstagen
Preis
207,00 CHFVerfügbarkeit:
LieferbarArtikel, die Sie kürzlich angesehen haben
Lieferbar in 48 Stunden
